Table 2.
Stroke subjects(n = 12) | Controls | |||
---|---|---|---|---|
Hemiparetic | Nonparetic | IGT (n = 12) | NGT (n = 12) | |
Overall share factor | 3.09 ± 0.04§ | 2.98 ± 0.05 | 3.05 ± 0.03 | 2.99 ± 0.05 |
Type I | 3.12 ± 0.07§,† | 2.94 ± 0.04 | 3.01 ± 0.03 | 2.96 ± 0.05 |
Type IIa | 3.07 ± 0.04 | 3.02 ± 0.05 | 3.08 ± 0.05 | 3.00±0.06 |
Type IIx | 3.01 ± 0.04 | 3.09 ± 0.04 | 3.15 ± 0.05 | 3.14 ± 0.05 |
Overall capillary contacts | 3.38 ± 0.24 ‖,‡ | 4.51 ± 0.36 | 4.02 ± 0.22 | 4.57 ± 0.23 |
Type I | 3.83 ± 0.22§,† | 4.85 ± 0.38 | 4.47 ± 0.23 | 4.84 ± 0.25 |
Type IIa | 3.23 ± 0.20*,‡ | 4.06 ± 0.41 | 3.72 ±.022 | 4.28 ± 0.25 |
Type IIx | 2.97 ± 0.27* | 3.43 ± 0.38 | 3.17 ± 0.15 | 3.52 ± 0.23 |
Overall individual capillary to fiber ratio | 1.16 ± 0.09‖,‡ | 1.62 ± 0.16 | 1.39 ± 0.09 | 1.63 ± 0.11 |
Type I | 1.31 ± 0.09§,‡ | 1.76 ± 0.17 | 1.57 ± 0.10 | 1.74 ± 0.11 |
Type IIa | 1.10 ± 0.08*,‡ | 1.44 ± 0.17 | 1.27 ± 0.10 | 1.50 ± 0.11 |
Type IIx | 1.02 ± 0.10* | 1.16 ± 0.14 | 1.05 ± 0.10 | 1.19 ± 0.09 |
Data are presented as mean±SEM.
Significant difference, compared to nonparetic leg muscle (*P <0.05, §P <0.01, ‖P <0.001);
significant difference, compared to NGT control muscle (†P <0.05, ‡P <0.01).